S 4509
PBM Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 24, 2026, 12:48 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Patients Before Monopolies Act, aims to address concerns about market concentration and potential conflicts of interest within the pharmaceutical supply chain. It prohibits pharmacy benefit managers (PBMs) and pharmacies from being owned by the same entity, arguing that this vertical integration can lead to higher drug prices and reduced competition. The bill seeks to structurally separate vertically integrated health conglomerates, require divestitures of pharmacy businesses, and empower federal agencies and state attorneys general to enforce these regulations.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.